Literature DB >> 12615424

Introduction of a HIV vaccine in developing countries: social and cultural dimensions.

P H Streefland1.   

Abstract

Using insights from studies on social and cultural aspects of immunization in Africa and Asia the paper discusses the introduction of a HIV vaccine from three perspectives. Firstly, it shows how at the side of public health programs local differences will impact on the introduction of a new vaccine. Secondly, it elaborates how at the side of the users of vaccinations acceptance, non-acceptance and demand of and for a new vaccine are related to local vaccination cultures, images of the HIV/AIDS epidemic, and perceptions of vaccine potency and efficacy. Thirdly, it points out socio-cultural aspects of the introductory process. Tailoring health education and social marketing to local conditions and local interpretations of globally provided information will be decisive for a successful introduction. Strong public health programs with highly motivated and appropriately supported staff are another necessary condition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615424     DOI: 10.1016/s0264-410x(02)00685-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Designing research in vulnerable populations: lessons from HIV prevention trials that stopped early.

Authors:  Edward J Mills; Sonal Singh; Jerome A Singh; James J Orbinski; Mitchell Warren; Ross E Upshur
Journal:  BMJ       Date:  2005-12-10

2.  Social and cultural determinants of oral cholera vaccine uptake in Zanzibar.

Authors:  Christian Schaetti; Said M Ali; Raymond Hutubessy; Ahmed M Khatib; Claire-Lise Chaignat; Mitchell G Weiss
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

3.  Lessons learned from COVID-19 vaccination in Indonesia: experiences, challenges, and opportunities.

Authors:  Bondi Arifin; Titik Anas
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

4.  Community participation in two vaccination trials in slums of Kolkata, India: a multi-level analysis.

Authors:  Mohammad Ali; Dipika Sur; Anna Lena Lopez; Suman Kanungo; R Leon Ochiai; Byomkesh Manna; Deok Ryun Kim; Jacqueline Deen; Sujit K Bhattacharya; John D Clemens
Journal:  J Health Popul Nutr       Date:  2010-10       Impact factor: 2.000

5.  Portrait of a lengthy vaccination trajectory in Burkina Faso: from cultural acceptance of vaccines to actual immunization.

Authors:  Marylène Dugas; Eric Dubé; Bocar Kouyaté; Aboubakary Sanou; Gilles Bibeau
Journal:  BMC Int Health Hum Rights       Date:  2009-10-14

6.  Community perceptions of malaria and vaccines in the South Coast and Busia regions of Kenya.

Authors:  David I Ojakaa; Peter Ofware; Yvonne W Machira; Emmanuel Yamo; Yvette Collymore; Antoinette Ba-Nguz; Preeti Vansadia; Allison Bingham
Journal:  Malar J       Date:  2011-05-30       Impact factor: 2.979

7.  In/dependent Collaborations: Perceptions and Experiences of African Scientists in Transnational HIV Research.

Authors:  Ferdinand Moyi Okwaro; P W Geissler
Journal:  Med Anthropol Q       Date:  2015-05-14

8.  Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach.

Authors:  Venkatesan Chakrapani; Peter A Newman; Neeti Singhal; Jhalak Jerajani; Murali Shunmugam
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

9.  Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance.

Authors:  Christian Schaetti; Raymond Hutubessy; Said M Ali; Al Pach; Mitchell G Weiss; Claire-Lise Chaignat; Ahmed M Khatib
Journal:  BMC Public Health       Date:  2009-04-07       Impact factor: 3.295

10.  Comparing sociocultural features of cholera in three endemic African settings.

Authors:  Christian Schaetti; Neisha Sundaram; Sonja Merten; Said M Ali; Erick O Nyambedha; Bruno Lapika; Claire-Lise Chaignat; Raymond Hutubessy; Mitchell G Weiss
Journal:  BMC Med       Date:  2013-09-18       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.